201 related articles for article (PubMed ID: 27956791)
1. Percutaneous ablation of pancreatic cancer.
D'Onofrio M; Ciaravino V; De Robertis R; Barbi E; Salvia R; Girelli R; Paiella S; Gasparini C; Cardobi N; Bassi C
World J Gastroenterol; 2016 Nov; 22(44):9661-9673. PubMed ID: 27956791
[TBL] [Abstract][Full Text] [Related]
2. Systematic review of novel ablative methods in locally advanced pancreatic cancer.
Keane MG; Bramis K; Pereira SP; Fusai GK
World J Gastroenterol; 2014 Mar; 20(9):2267-78. PubMed ID: 24605026
[TBL] [Abstract][Full Text] [Related]
3. Ablation of the locally advanced pancreatic cancer: An introduction and brief summary of techniques.
Petrou A; Moris D; Paul Tabet P; David Wensley Richards B; Kourounis G
J BUON; 2016; 21(3):650-8. PubMed ID: 27569086
[TBL] [Abstract][Full Text] [Related]
4. Percutaneous Approach to Irreversible Electroporation of the Pancreas: Miami Protocol.
Venkat S; Hosein PJ; Narayanan G
Tech Vasc Interv Radiol; 2015 Sep; 18(3):153-8. PubMed ID: 26365545
[TBL] [Abstract][Full Text] [Related]
5. Ablation Strategies for Locally Advanced Pancreatic Cancer.
Linecker M; Pfammatter T; Kambakamba P; DeOliveira ML
Dig Surg; 2016; 33(4):351-9. PubMed ID: 27216160
[TBL] [Abstract][Full Text] [Related]
6. Irreversible Electroporation for Locally Advanced Pancreatic Cancer.
Timmer FEF; Geboers B; Ruarus AH; Schouten EAC; Nieuwenhuizen S; Puijk RS; de Vries JJJ; Meijerink MR; Scheffer HJ
Tech Vasc Interv Radiol; 2020 Jun; 23(2):100675. PubMed ID: 32591191
[TBL] [Abstract][Full Text] [Related]
7. Percutaneous Image-Guided Irreversible Electroporation for the Treatment of Unresectable, Locally Advanced Pancreatic Adenocarcinoma.
Narayanan G; Hosein PJ; Beulaygue IC; Froud T; Scheffer HJ; Venkat SR; Echenique AM; Hevert EC; Livingstone AS; Rocha-Lima CM; Merchan JR; Levi JU; Yrizarry JM; Lencioni R
J Vasc Interv Radiol; 2017 Mar; 28(3):342-348. PubMed ID: 27993507
[TBL] [Abstract][Full Text] [Related]
8. Minimally invasive image-guided therapy of primary and metastatic pancreatic cancer.
Bibok A; Kim DW; Malafa M; Kis B
World J Gastroenterol; 2021 Jul; 27(27):4322-4341. PubMed ID: 34366607
[TBL] [Abstract][Full Text] [Related]
9. Needle-guided ablation of locally advanced pancreatic cancer: cytoreduction or immunomodulation by in vivo vaccination?
Geboers B; Ruarus AH; Nieuwenhuizen S; Puijk RS; Scheffer HJ; de Gruijl TD; Meijerink MR
Chin Clin Oncol; 2019 Dec; 8(6):61. PubMed ID: 31865711
[TBL] [Abstract][Full Text] [Related]
10. A single center experience in resectable pancreatic ductal adenocarcinoma : the limitations of the surgery-first approach. Critical review of the literature and proposals for practice update.
Dumont R; Puleo F; Collignon J; Meurisse N; Chavez M; Seidel L; Gast P; Polus M; Loly C; Delvenne P; Meunier P; Hustinx R; Deroover A; Detry O; Louis E; Martinive P; Van Daele D
Acta Gastroenterol Belg; 2017; 80(4):451-461. PubMed ID: 29560639
[TBL] [Abstract][Full Text] [Related]
11. An update on the role of irreversible electroporation in locally advanced pancreatic adenocarcinoma.
Martin RCG
HPB (Oxford); 2016 Oct; 18(10):791-792. PubMed ID: 27542589
[No Abstract] [Full Text] [Related]
12. Local ablation for hepatocellular carcinoma.
Boyvat F
Exp Clin Transplant; 2014 Mar; 12 Suppl 1():55-9. PubMed ID: 24635794
[TBL] [Abstract][Full Text] [Related]
13. Local ablation of pancreatic tumors: State of the art and future perspectives.
Granata V; Grassi R; Fusco R; Belli A; Palaia R; Carrafiello G; Miele V; Grassi R; Petrillo A; Izzo F
World J Gastroenterol; 2021 Jun; 27(23):3413-3428. PubMed ID: 34163121
[TBL] [Abstract][Full Text] [Related]
14. Radiofrequency ablation for locally advanced pancreatic cancer: SMAD4 analysis segregates a responsive subgroup of patients.
Paiella S; Malleo G; Cataldo I; Gasparini C; De Pastena M; De Marchi G; Marchegiani G; Rusev B; Scarpa A; Girelli R; Giardino A; Frigerio I; D'Onofrio M; Secchettin E; Bassi C; Salvia R
Langenbecks Arch Surg; 2018 Mar; 403(2):213-220. PubMed ID: 28983662
[TBL] [Abstract][Full Text] [Related]
15. The efficacy and safety of the open approach irreversible electroporation in the treatment of pancreatic cancer: A systematic review.
Charalambous P; Moris D; Karachaliou GS; Papalampros A; Dimitrokallis N; Tsilimigras DI; Oikonomou D; Petrou A
Eur J Surg Oncol; 2020 Sep; 46(9):1565-1572. PubMed ID: 32536525
[TBL] [Abstract][Full Text] [Related]
16. Radiofrequency ablation of liver metastasis in patients with locally controlled pancreatic ductal adenocarcinoma.
Park JB; Kim YH; Kim J; Chang HM; Kim TW; Kim SC; Kim PN; Han DJ
J Vasc Interv Radiol; 2012 May; 23(5):635-41. PubMed ID: 22525021
[TBL] [Abstract][Full Text] [Related]
17. Survival impact of distal pancreatectomy with en bloc celiac axis resection combined with neoadjuvant chemotherapy for borderline resectable or locally advanced pancreatic body carcinoma.
Murakami Y; Nakagawa N; Kondo N; Hashimoto Y; Okada K; Seo S; Otsuka H
Pancreatology; 2021 Apr; 21(3):564-572. PubMed ID: 33526385
[TBL] [Abstract][Full Text] [Related]
18. Role of local ablative techniques (Radiofrequency ablation and Irreversible Electroporation) in the treatment of pancreatic cancer.
Paiella S; Salvia R; Girelli R; Frigerio I; Giardino A; D'Onofrio M; De Marchi G; Bassi C
Updates Surg; 2016 Sep; 68(3):307-311. PubMed ID: 27535401
[TBL] [Abstract][Full Text] [Related]
19. Results of 100 pancreatic radiofrequency ablations in the context of a multimodal strategy for stage III ductal adenocarcinoma.
Girelli R; Frigerio I; Giardino A; Regi P; Gobbo S; Malleo G; Salvia R; Bassi C
Langenbecks Arch Surg; 2013 Jan; 398(1):63-9. PubMed ID: 23053459
[TBL] [Abstract][Full Text] [Related]
20. Stage III pancreatic cancer and the role of irreversible electroporation.
Al Efishat M; Wolfgang CL; Weiss MJ
BMJ; 2015 Mar; 350():h521. PubMed ID: 25787829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]